Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia, or hair loss, is caused by genetic factors and hormones, with different mechanisms in men and women, and can be linked to insulin resistance and polycystic ovary syndrome.

A young man developed a rare, bilateral scalp condition after head trauma, causing hair loss but no neurological or eye issues.

The combination of oral minoxidil, oral dutasteride, and mesotherapy is the most effective and safe for hair growth in AGA.

Botulinum toxin is used for neck, shoulder, calf, and ankle slimming, and hair loss treatment, but can cause muscle weakness and atrophy with regular use.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

A rare skin condition causing scarring was successfully treated with topical erythromycin and benzoyl peroxide.

Scalp edema may be a new variant of conditions reacting to scarring alopecia like LPP.

Myotonic Dystrophy may age cells faster, and drugs that target aging could be potential treatments.

Individualized assessment and meticulous planning are crucial for successful brow and upper eyelid surgery.

Androgenetic alopecia in Nepalese men often starts around age 29, with a possible link to COVID-19 worsening the condition.

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.

One-third of COVID-19 patients had long-term symptoms like hair loss and fatigue, with women, older individuals, blood group B, smokers, and those with more virus exposure at higher risk.

The hair follicle dermal sheath is essential for hair shedding and needs to communicate with the outer root sheath for normal hair growth cycles.

Blocking JAK-STAT5 signaling in mice leads to hair growth.

Hair loss patterns differ between males and females due to 5 master regulators and JAK-STAT signaling affects hair growth.

Perifollicular erythema can indicate active frontal fibrosing alopecia.

Two patients with skin lupus were mistakenly thought to have a different scalp condition but improved with lupus treatment.

The paper concludes that creating a natural-looking hairline in hair restoration is important for facial aesthetics and involves careful planning and realistic expectations.

Stem cell treatment improved hair density in female hair loss patient.

Removing STAT5 from 3D-cultured human skin cells reduces their ability to grow hair.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.

Finasteride significantly improves hair growth but may cause sexual side effects.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Researchers created a new system to classify male baldness, finding six types and a common hairline shape, to improve hair loss treatments.

Occipital scalp affects female hair loss; terminal/vellus ratio helps diagnose androgenetic alopecia.

Researchers found a new early sign of Frontal Fibrosing Alopecia that could help avoid misdiagnosis.

Camouflaging agents like hair fibers and wigs significantly improve appearance and self-esteem for most hair loss patients.

Temporal hair loss relates to overall scalp hair loss in women.

Lower hairlines using the rule of thirds can be used in hair transplants due to improved techniques.